Gilead’s COVID-19 drug costs $2,340. Experts say that’s a ‘responsible’ price
June 29, 2020 at 13:22 PM EDT
Gilead Sciences Inc.’s COVID-19 drug remdesivir will cost much less than Wall Street analysts had predicted in a move that likely points to a more measured, responsible approach to the pharmaceutical pricing of treatments and vaccines during the pandemic.